Stock A034940 CHOA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ChoA Pharmaceutical Co., LTD.

Equities

A034940

KR7034940007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
1,617 KRW 0.00% Intraday chart for ChoA Pharmaceutical Co., LTD. -2.77% -18.37%
2023 ChoA Pharmaceutical Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2022 ChoA Pharmaceutical Co., LTD.(KOSDAQ:A034940) dropped from S&P Global BMI Index CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 123,574 107,013 154,280 116,484 72,957 61,371
Enterprise Value (EV) 1 125,725 110,220 155,479 122,774 83,186 74,512
P/E ratio 193 x -118 x -117 x -14.5 x 130 x -5.84 x
Yield - - - - - -
Capitalization / Revenue 1.96 x 1.58 x 2.36 x 2.02 x 1.06 x 0.97 x
EV / Revenue 1.99 x 1.63 x 2.38 x 2.13 x 1.21 x 1.18 x
EV / EBITDA 36.7 x 45.9 x 130 x -29.9 x 43.6 x -11.6 x
EV / FCF -265 x 53 x -95.8 x -39.7 x -24.9 x -87.6 x
FCF Yield -0.38% 1.89% -1.04% -2.52% -4.01% -1.14%
Price to Book 2.29 x 2.02 x 2.65 x 2.33 x 1.38 x 1.5 x
Nbr of stocks (in thousands) 28,310 28,310 30,980 30,980 30,980 30,980
Reference price 2 4,365 3,780 4,980 3,760 2,355 1,981
Announcement Date 14/03/19 16/03/20 19/03/21 18/03/22 17/03/23 15/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 63,090 67,537 65,360 57,561 68,880 62,974
EBITDA 1 3,430 2,403 1,194 -4,109 1,906 -6,405
EBIT 1 1,325 -408.4 -1,856 -7,003 -482.2 -8,792
Operating Margin 2.1% -0.6% -2.84% -12.17% -0.7% -13.96%
Earnings before Tax (EBT) 1 372.1 -1,156 -1,767 -7,146 -424.4 -10,934
Net income 1 641.1 -905.3 -1,319 -8,044 560.7 -10,514
Net margin 1.02% -1.34% -2.02% -13.97% 0.81% -16.7%
EPS 2 22.65 -32.00 -42.57 -259.6 18.10 -339.4
Free Cash Flow 1 -474.5 2,081 -1,623 -3,096 -3,337 -850.3
FCF margin -0.75% 3.08% -2.48% -5.38% -4.84% -1.35%
FCF Conversion (EBITDA) - 86.61% - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 14/03/19 16/03/20 19/03/21 18/03/22 17/03/23 15/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2,151 3,207 1,199 6,289 10,229 13,141
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.6271 x 1.335 x 1.004 x -1.531 x 5.367 x -2.052 x
Free Cash Flow 1 -474 2,081 -1,623 -3,096 -3,337 -850
ROE (net income / shareholders' equity) 1.16% -2.14% -2.96% -15.3% 1.03% -24.7%
ROA (Net income/ Total Assets) 0.99% -0.3% -1.37% -5.37% -0.36% -6.87%
Assets 1 64,860 302,982 96,145 149,685 -154,589 152,947
Book Value Per Share 2 1,906 1,874 1,882 1,611 1,706 1,323
Cash Flow per Share 2 358.0 355.0 134.0 186.0 146.0 66.10
Capex 1 1,972 1,389 3,598 3,544 2,782 831
Capex / Sales 3.13% 2.06% 5.51% 6.16% 4.04% 1.32%
Announcement Date 14/03/19 16/03/20 19/03/21 18/03/22 17/03/23 15/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHOA PHARMACEUTICAL CO., LTD. Stock ChoA Pharmaceutical Co., LTD.
-18.37% 36.83M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+22.35% 44.12B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.22% 22.61B
SANDOZ GROUP AG Stock Sandoz Group AG
+17.81% 15.11B
CIPLA LIMITED Stock Cipla Limited
+15.73% 13.61B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+57.91% 13.34B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.98% 6.94B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+15.65% 5.75B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A034940 Stock
  4. Financials ChoA Pharmaceutical Co., LTD.